• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Acute Crit Care . COVID-19-induced acute kidney injury in critically ill patients: epidemiology, risk factors, and outcome

tetano

Editor, Senior Moderator
Acute Crit Care


. 2021 Nov;36(4):308-316.
doi: 10.4266/acc.2021.00934. Epub 2021 Nov 22.
COVID-19-induced acute kidney injury in critically ill patients: epidemiology, risk factors, and outcome


Ahlem Trifi[SUP] 1 2 [/SUP], Sami Abdellatif[SUP] 1 2 [/SUP], Yosri Masseoudi[SUP] 2 3 [/SUP], Asma Mehdi[SUP] 1 2 [/SUP], Oussama Benjima[SUP] 2 3 [/SUP], Eya Seghir[SUP] 1 2 [/SUP], Fatma Cherif[SUP] 2 3 [/SUP], Yosr Touil[SUP] 1 2 [/SUP], Bedis Jeribi[SUP] 2 3 [/SUP], Foued Daly[SUP] 1 2 [/SUP], Cyrine Abdennebi[SUP] 1 2 [/SUP], Adel Ammous[SUP] 2 3 [/SUP], Salah Ben Lakhal[SUP] 1 2 [/SUP]



Affiliations

Abstract

Background: The kidney represents a potential target for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Clinical data about acute kidney injury (AKI) during SARS-CoV-2 infection are lacking. We aimed to investigate the proportion, risk factors, and prognosis of AKI in critical patients affected with SARS-CoV-2.
Methods: A case/control study was conducted in two intensive care units of a tertiary teaching hospital.
Results: Among 109 patients, 75 were male (69%) with median age at 64 years and 48 (44%) developed AKI within 4 days (interquartile range [IQR], 1-9). Of them, 11 (23%), 9 (19%), and 28 (58%) were classified as stage 1, 2, and 3, respectively. AKI patients were older and presented more sepsis, acute respiratory distress syndrome, and rhabdomyolysis; higher initial urea and creatinine; more marked inflammatory syndrome and hematological disorders; and required more mechanical ventilation and vasopressors. An elevated D-dimers level (odds ratio [OR], 12.83; 95% confidence interval [CI], 1.9-85) was an independent factor of AKI. Sepsis was near to significance (OR, 5.22; 95% CI, 0.94-28; P=0.058). AKI was independently related to mortality (OR, 6.8; 95% CI, 1.49-105) and significantly reduced the survival (14.7 days; IQR, 12-17 vs. 19.9 days; IQR, 17-22.7; P=0.011) in AKI and no AKI group respectively. Hypoxemia with the ratio of the arterial partial pressure of oxygen and the inspiratory concentration of oxygen <70, and vasopressors were identified as mortality factors.
Conclusions: AKI occurred in almost half the studied patients and significantly worsened their prognosis. A high D-dimers level and sepsis contributed significantly to its development.

Keywords: acute kidney injury; coronavirus disease 2019; mechanical ventilation; mortality.
 
Back
Top Bottom